Intravenous Immunoglobulin in the Treatment of Adalimumab-associated Optic Neuritis.

MLA

Uchio, Naohiro, et al. “Intravenous Immunoglobulin in the Treatment of Adalimumab-Associated Optic Neuritis.” Internal Medicine (Tokyo, Japan), vol. 61, no. 3, Feb. 2022, pp. 429–32. EBSCOhost, https://doi.org/10.2169/internalmedicine.7599-21.

APA

Uchio, N., Yashita, D., Hao, A., Takahashi, T., & Matsumoto, H. (2022). Intravenous Immunoglobulin in the Treatment of Adalimumab-associated Optic Neuritis. Internal Medicine (Tokyo, Japan), 61(3), 429–432. https://doi.org/10.2169/internalmedicine.7599-21

Chicago

Uchio, Naohiro, Daiki Yashita, Akihito Hao, Toshiyuki Takahashi, and Hideyuki Matsumoto. 2022. “Intravenous Immunoglobulin in the Treatment of Adalimumab-Associated Optic Neuritis.” Internal Medicine (Tokyo, Japan) 61 (3): 429–32. doi:10.2169/internalmedicine.7599-21.